BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 13, 2020
View Archived Issues
Integrated herpesvirus 6 is pre-eclampsia risk factor
Read More
Sorrento Therapeutics and Mount Sinai partner on antibody cocktail for COVID-19
Read More
Tukysa approved in Switzerland for metastatic HER2-positive breast cancer
Read More
GALNT14 GG genotype as prognostic biomarker in PDA
Read More
Decreased SLC39A1 expression is associated with poor prognosis in HCC
Read More
AQX-435 shows promising activity in models of B-cell malignancies
Read More
ALS-8112, a parent nucleoside of lumicitabine, inhibits Nipah virus in vitro
Read More
Phase III data presented on fexuprazan in patients with erosive esophagitis
Read More
miR-802 overexpression links obesity with impaired insulin transcription and secretion
Read More
NTRK1 inhibitors discovered at Medshine Discovery
Read More
Step Pharma identifies new CTP synthase 1 inhibitors
Read More
Myelopro Diagnostics & Research presents new compounds binding to calreticulin
Read More
Enabling P-TEFb-dependent transcription of Myc in heart restores cardiomyocyte proliferation
Read More
New anthelmintic compounds patented by Bayer
Read More
C4X Discovery Holdings presents NFE2-related factor 2 activators
Read More
New biomarker identified for the aging brain
Read More
Blade Therapeutics begins phase II study of BLD-2660 in hospitalized patients with COVID-19
Read More
Genocea eyes IND filing for neoantigen cell therapy GEN-011
Read More
Arrowhead opens enrollment in phase Ib study of ARO-HIF2 in advanced clear cell renal cell carcinoma
Read More
Veru cleared by FDA to begin phase II study of VERU-111 for COVID-19
Read More
TransThera studies TT-00920 for heart failure in first-in-human study
Read More
New compounds target SARS-CoV-2 main protease Mpro
Read More